| Accountable Care Organization 2014 Quality Performance Summary Statistics Report | |||||
| TP-ACO L.L.C. | |||||
| Domain | Measure Number | Measure Name | TP-ACO Performance Rate | Mean Performance Rate All ACOs | |
| Patient/Caregiver Experience | ACO-1 | Getting Timely Care, Appointments, and Information | 81.24 | 80.13 | |
| ACO-2 | How Well Your Doctors Communicate | 94.50 | 92.39 | ||
| ACO-3 | Patients’ Rating of Doctor | 92.50 | 91.58 | ||
| ACO-4 | Access to Specialists | 84.85 | 83.97 | ||
| ACO-5 | Health Promotion and Education | 61.28 | 58.29 | ||
| ACO-6 | Shared Decision Making | 78.16 | 74.60 | ||
| ACO-7 | Health Status/Functional Status | 69.28 | 71.10 | ||
| Care Coordination/Patient Safety | ACO-8 | Risk Standardized, All Condition Readmissions | 14.32 | 15.15 | |
| ACO-9 | ASC Admissions: COPD or Asthma in Older Adults | 1.74 | 1.08 | ||
| ACO-10 | ASC Admission: HF | 1.21 | 1.19 | ||
| ACO-11 | Percent of Primary Care Providers Who Successfully Attested for the EHR Incentive Program Incentive Payment | 59.70% | 76.71% | ||
| ACO-12 | Medication Reconciliation | 95.79% | 82.61% | ||
| ACO-13 | Falls: Screening for Fall Risk | 64.83% | 45.60% | ||
| Preventive Health | ACO-14 | Influenza Immunization | 57.38% | 57.51% | |
| ACO-15 | Pneumococcal Vaccination | 52.52% | 55.03% | ||
| ACO-16 | Adult Weight Screening and Follow-up | 70.28% | 66.75% | ||
| ACO-17 | Tobacco Use Assessment and Cessation Intervention | 82.86% | 86.79% | ||
| ACO-18 | Depression Screening | 44.13% | 39.27% | ||
| ACO-19 | Colorectal Cancer Screening | 47.28% | 56.14% | ||
| ACO-20 | Mammography Screening | 46.47% | 61.41% | ||
| ACO-21 | Proportion of Adults who had blood pressure screened in past 2 years | 71.36% | 60.24% | ||
| At Risk Population | Diabetes Composite | Beneficiaries with diabetes who met of all the following criteria: | 0.00% | 25.41% | |
| ACO-22 | Hemoglobin A1c Control (HbA1c) (<8 percent) | 64.96% | 25.41% | ||
| ACO-23 | Low Density Lipoprotein (LDL) (< 100 mg/dL) | 0.00% | 25.41% | ||
| ACO-24 | Blood Pressure (BP) < 140/90 | 58.39% | 25.41% | ||
| ACO-25 | Tobacco Non-Use | 67.88% | 25.41% | ||
| ACO-26 | Aspirin Use | 51.89% | 25.41% | ||
| ACO-27 | Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) | 27.74% | 20.35% | ||
| ACO-28 | Percent of beneficiaries with hypertension whose BP < 140/90 | 60.96% | 68.02% | ||
| ACO-29 | Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl | 48.00% | 57.29% | ||
| ACO-30 | Percent of beneficiaries who use Aspirin or other antithrombotic | 75.78% | 80.79% | ||
| ACO-31 | Beta-Blocker Therapy for LVSD | 95.83% | 82.71% | ||
| CAD Composite | Percent of beneficiaries with CAD who met all of the following criteria: | 56.45% | 66.90% | ||
| ACO-32 | Drug Therapy for Lowering LDL-Cholesterol | 63.02% | 66.90% | ||
| ACO-33 | (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) | 61.74% | 66.90% | ||